COVID-19 updates: Elizabeth Warren tests positive
The senator says she's experiencing "mild symptoms."
As the COVID-19 pandemic has swept the globe, more than 5.3 million people have died from the disease worldwide, including over 806,000 Americans, according to real-time data compiled by Johns Hopkins University's Center for Systems Science and Engineering.
About 61.4% of the population in the United States is fully vaccinated against COVID-19, according to data from the Centers for Disease Control and Prevention.
Latest headlines:
Omicron will be dominant variant in US 'very soon,' Fauci says
Dr. Anthony Fauci, the nation's leading expert on infectious diseases, warned Thursday that omicron will become the dominant variant of the novel coronavirus in the United States "very soon."
"It has an extraordinary ability to transmit efficiently and spread," Fauci, the chief medical advisor to U.S. President Joe Biden, told ABC News' George Stephanopoulos in an interview on "Good Morning America."
"It has what we call a doubling time of about three days and if you do the math on that, if you have just a couple of percentage of the isolates being omicron, very soon it's going to be the dominant variant," he explained. "We've seen that in South Africa, we're seeing it in the U.K. and I'm absolutely certain that's what we're going to be seeing here relatively soon."
Fauci, who is also the director of the National Institute of Allergy and Infectious Diseases, urged Americans to "absolutely" get vaccinated against COVID-19, if they haven't already, and to also receive a booster shot when they become eligible.
"At this point, we don't believe you need an omicron-specific boost," he added. "We just need to get the boost with what you got originally for the primary vaccination."
France to ban non-essential travel with UK over omicron surge
France announced Thursday that it will ban non-essential travel to and from the United Kingdom due to the country's surge in cases of the omicron variant.
Starting Saturday, France will require people to have "a compelling reason" to travel between the two countries. Travel for tourism or work will not be allowed. French citizens, however, can return to France, according to a statement from the French prime minister's office.
All travelers from the U.K. will be required to show proof of a negative COVID-19 test taken less than 24 hours before departure. Upon arrival in France, they must self-isolate for a week, but that period can be ended after 48 hours if they test negative for COVID-19 again.
The new rules apply to people regardless of their vaccination status.
"Faced with the extremely rapid spread of the Omicron variant in the United Kingdom, the Government has chosen to reinstate the need for an essential reason for travel from and to the United Kingdom, and to strengthen the requirement for tests on departure and arrival," the French prime minister's office said in the statement Thursday. "The Government is also calling on travelers who had planned to visit the United Kingdom to postpone their trip."
Indonesia confirms 1st case of omicron variant
Indonesia announced Thursday its first confirmed case of the omicron variant.
The case was detected in a janitor who works at the COVID-19 Emergency Hospital of Kemayoran Athletes Village in Jakarta, according to a statement from Indonesian Health Minister Budi Gunadi Sadikin.
The hospital's cleaning staff are routinely tested and the results for three people were positive for COVID-19 on Dec. 10. Those samples were then sent to a genome sequencing lab, which identified the omicron variant in one of the samples on Wednesday, according to the statement.
Indonesia's Ministry of Health has also identified probable cases of omicron among five travelers who were in quarantine -- two Indonesian citizens who had just returned from the United Kingdom and the United States, and three foreigners from China. Their test samples are being sequenced and the results will be known in a few days, according to the statement.
The health minister urged Indonesians "not to panic and to remain calm," and to get vaccinated against COVID-19 if they haven't already.
"The arrival of new variants from abroad, which we identified in quarantine, shows that our defense system against the arrival of new variants is quite good, we need to strengthen it," Sadikin said. "So it's normal to stay 10 days in quarantine. The goal is not to make it difficult for people who came, but to protect the people of Indonesia."
Forecast: US could see up to 845,000 deaths by early January
Forecast models used by the CDC suggest weekly death totals and hospital admissions will rise over the next four weeks.
The U.S. could reach a total of 845,000 deaths by Jan. 8, according to the forecasts from the COVID-19 Forecast Hub at UMass Amherst.
The COVID-19 Forecast Hub team monitors and combines forecasting models from the nation’s top researchers. They then create an ensemble, usually with a wide cone of uncertainty. Nicholas Reich, a biostatistician who runs the forecasting model, told ABC News Wednesday that he doesn't think the forecasts included omicron in their predictions because the majority of data isn't publicly available yet in a format that can be easily incorporated into a model.
-ABC News' Arielle Mitropoulos
Omicron appears to spread faster and vaccine less effective against it, WHO says
The omicron variant appears to have a "growth advantage" over the delta variant, the World Health Organization said in a technical brief released Sunday.
"It is spreading faster than the delta variant in South Africa where delta circulation was low, but also appears to spread more quickly than the delta variant in other countries where the incidence of delta is high, such as in the United Kingdom," the WHO said in the brief, which was dated Friday. "Whether omicron's observed rapid growth rate in countries with high levels of population immunity is related to immune evasion, intrinsic increased transmissibility, or a combination of both remains uncertain. However, given the current available data, it is likely that omicron will outpace the delta variant where community transmission occurs."
Meanwhile, preliminary findings from South Africa suggest omicron may cause less severe illness than delta, and all cases of omicron reported in Europe to date have been mild or asymptomatic. But the WHO said "it remains unclear to what extent omicron may be inherently less virulent" and that "more data are needed to understand the severity profile."
The WHO also noted that "there are limited available data, and no peer-reviewed evidence, on vaccine efficacy or effectiveness to date for omicron." However, preliminary evidence, and the considerably altered antigenic profile of the variant's spike protein, suggests a reduction in vaccine efficacy against infection and transmission associated with omicron.
"There is some preliminary evidence that the incidence of reinfection has increased in South Africa, which may be associated with humoral (antibody-mediated) immune evasion," the WHO said.
The diagnostic accuracy of routinely used polymerase chain reaction (PCR) test and antigen-based rapid diagnostic test (Ag-RDT) assays does not appear to be influenced by omicron. Therapeutic interventions for the management of severe or critical COVID-19 symptoms associated with omicron are also expected to remain effective, according to the WHO.
"However, monoclonal antibodies will need to be tested individually, for their antigen binding and virus neutralization and these studies should be prioritized," the WHO added.
-ABC News' Christine Theodorou